Home/Filings/4/0000899243-23-010391
4//SEC Filing

Ros Matthew 4

Accession 0000899243-23-010391

CIK 0001622229other

Filed

Apr 3, 8:00 PM ET

Accepted

Apr 4, 4:15 PM ET

Size

5.8 KB

Accession

0000899243-23-010391

Insider Transaction Report

Form 4
Period: 2023-04-03
Ros Matthew
Director
Transactions
  • Award

    Stock Option (Right to Buy)

    2023-04-03+1,9001,900 total
    Exercise: $10.75From: 2023-04-03Exp: 2033-04-03Common Stock (1,900 underlying)
Footnotes (1)
  • [F1]The option award was issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation plan. The number of options granted was determined by dividing the cash compensation otherwise payable with respect to the quarter by the Black-Scholes value of a single option calculated as of the date of the grant.

Issuer

Cogent Biosciences, Inc.

CIK 0001622229

Entity typeother

Related Parties

1
  • filerCIK 0001673802

Filing Metadata

Form type
4
Filed
Apr 3, 8:00 PM ET
Accepted
Apr 4, 4:15 PM ET
Size
5.8 KB